Precision that changes outcomes

PATIENT impact
<5-minute system deployment with no skull fixation required, enabling deployment in virtually any operative setting, including emergency rooms and ambulatory centers.
100% single-pass accuracy of EVD catheter placement in a multi-center study – eliminating the need for catheter revisions and reducing the risk of ventriculostomy-related infection.
Reduces the risk of post-operative pulmonary complications and injuries associated with skull fixation in cranial procedures.
STAFFING IMPACT
No anesthesiologist or surgical tech required, thanks to a simplified workflow.
Patients can bypass Phase I PACU for procedures such as brain biopsy, reducing nursing hours and post-op care resources.
Reduces reliance on neuro-OR scrub nurses and radiology techs by taking cranial surgeries outside of the OR, easing staffing bottlenecks.
FINANCIAL IMPACT
Saves $2,150–$2,628 per EVD by avoiding costly catheter replacements and infection treatment.
Reduces $1,800 in variable OR costs per brain biopsy by minimizing procedure time.
Moving procedures such as brain biopsy cases away from neuro OR enables additional OR surgeries with up to $9,000 contribution margin per case — totaling $1.4M/year in added value for 200 annual cases.
WORKFLOW
Reduces procedure time from 5 hours to <3 hours for brain biopsies, improving case throughput.
Enables procedures outside the OR, freeing up premium surgical time for complex cases.
Submillimeter precision maintained in cranial procedures in real time even with rapid patient movement.
May 2026
Zeta Navigation System, alongside its navigated instruments, Zeta Stylet and Zeta Bolt, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Zeta Surgical® Receives FDA 510(k) Clearance Expanding Access to Brain Tumor Biopsies, Hydrocephalus, and Trigeminal Neuralgia
READ MORE
READ MORE
NEWS
PUBLICATION
READ MORE
READ MORE
NEWS
PUBLICATION
Apr 2026
The prototype is being developed in partnership with Zeta Surgical, Inc., whose AI-powered neuronavigation platform received FDA 510(k) clearance for TMS navigation in October 2025.
NRx Pharmaceuticals Advances Robotic-Enabled Transcranial Magnetic Stimulation Combined with Neuroplastic Therapy for Military and First Responder Applications
READ MORE
READ MORE
NEWS
PUBLICATION
READ MORE
READ MORE
NEWS
PUBLICATION
Feb 2026
The core of Zeta’s marker-less, real-time image guidance—built for fast setup and sub-millimetric accuracy in real clinical workflows.
REALTRACK™ Foundational Patent Published
READ MORE
READ MORE
NEWS
PUBLICATION
READ MORE
READ MORE
NEWS
PUBLICATION
Oct 2025
Zeta TMS Navigation System 510(k) FDA approval
Zeta Surgical® AI-powered TMS Navigation System Receives FDA 510(k) Clearance
READ MORE
READ MORE
NEWS
PUBLICATION
READ MORE
READ MORE
NEWS
PUBLICATION